The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
39
No.
40
October 25, 2013
- Building Boom of Proton Beam Centers Flares Up in Washington and Baltimore
- Conversation with Walter Curran – Proton Therapy: What’s Known and What’s Not
- NEJM Paper: Ownership of IMRT Centers Prompts Urologists to Refer Patients to Radiation Therapy
- Institute of Medicine Elects 70 Members at Annual Meeting
- NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies
CCL
Vol.
36
No.
10
October 25, 2013
- Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival
- Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years
- Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer
- ASCO and CAP Issue Guideline To Improve HER2 Testing
- Phase III Ramucirumab Trial Fails Primary Endpoint of PFS
- Kadcyla Extends Median PFS In Open-Label Phase III Trial
- Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease
- Colon Polyps in Elderly Patients Are More Likely to Be Found Only with Colonoscopy
- Phase III Vaccine Trial Fails To Improve Overall Survival
- Central Line Safety Intervention Lowers Patient Infection Rate
- Phase II Study Shows Positive Results in Reducing Dry Mouth
- NCI CTEP Approved Trials For the Month of October
TCL
Vol.
39
No.
41
November 01, 2013
- In the Cancer Centers: Rosen Moves To City Of Hope
- Conversation with The Cancer Letter: Rosen’s New Role Is Part Of An Evolution Of Administrative Structure at City of Hope
- Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care
- Cost of Care: Medicare Patients Charged More In Outpatient Care Settings
- In Brief: Larry Kun Was Named Clinical Director and Executive Vice President of St. Jude Children’s Research Hospital
TCL
Vol.
39
No.
42
November 08, 2013
- Conversation With The Cancer Letter: Wicha to Leave Director’s Job at UMich
- “Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor
- In Brief: LYNNE PENBERTHY Was Named Associate Director For Surveillance Research In NCI’s Division of Cancer Control and Population Sciences
TCL
Vol.
39
No.
44
November 22, 2013
- Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data
- NCI News: Biospecimen Banks Program for NCTN
- Moves Forward With Approval From BSA
- Obituary: Piotr Kulesza, 46, Pathologist At Northwestern, ECOG-ACRIN, Dies in Fall After Group Meeting
- In Brief: AMY ABERNETHY Was Named Chair of a New CancerLinQ Advisory Committee Within the Institute for Quality, An Affiliate Of The American Society of Clinical Oncology.
CCL
Vol.
36
No.
11
November 29, 2013
- Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival
- Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response
- FDA Grants Accelerated Approval to Imbruvica
- Two Papers Evaluate CyberKnife Survival Rates and Tolerability
- ANG1005 Demonstrates Activity In Patients with Brain Metastases
- MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues
- AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial
- NCI CTEP Approved Trials For the Month of November
TCL
Vol.
39
No.
46
December 13, 2013
- What Is and Isn’t a Crime in Texas: CPRIT Official Indicted For Skipping Peer Review
- Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me
- Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023
- In Brief: THOMAS BURKE Stepped Down As Executive Vice President And Physician-In-Chief at MD Anderson Cancer Center To Accept The New Position Of Executive Vice President of the MD Anderson Cancer Network
